Business Description
EPS Bio Technology Corp
NAICS : 334510
ISIN : TW0004183009
Description
EPS Bio Technology Corp operates in the medical industry. The company is a manufacturer of glucose meter and strips to develop diabetic self-monitoring blood glucose system. Its product includes MDT2, EME and EMMU.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.7 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 2.15 | |||||
| Interest Coverage | 13.17 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.27 | |||||
| Beneish M-Score | -2.27 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.5 | |||||
| 3-Year EBITDA Growth Rate | -9.8 | |||||
| 3-Year EPS without NRI Growth Rate | -13.6 | |||||
| 3-Year FCF Growth Rate | -14.4 | |||||
| 3-Year Book Growth Rate | -0.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 62.2 | |||||
| 9-Day RSI | 58.12 | |||||
| 14-Day RSI | 55.67 | |||||
| 6-1 Month Momentum % | -21.47 | |||||
| 12-1 Month Momentum % | 11.99 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.46 | |||||
| Quick Ratio | 2.77 | |||||
| Cash Ratio | 1.92 | |||||
| Days Inventory | 85.14 | |||||
| Days Sales Outstanding | 64.19 | |||||
| Days Payable | 73.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.41 | |||||
| Dividend Payout Ratio | 0.77 | |||||
| 3-Year Dividend Growth Rate | 11.9 | |||||
| Forward Dividend Yield % | 4.41 | |||||
| 5-Year Yield-on-Cost % | 11.11 | |||||
| Shareholder Yield % | 5.53 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.21 | |||||
| Operating Margin % | 5.85 | |||||
| Net Margin % | 6.36 | |||||
| FCF Margin % | 5.93 | |||||
| ROE % | 9.93 | |||||
| ROA % | 5.62 | |||||
| ROIC % | 9.67 | |||||
| ROC (Joel Greenblatt) % | 17.39 | |||||
| ROCE % | 9.14 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.56 | |||||
| PE Ratio without NRI | 17.46 | |||||
| Shiller PE Ratio | 19.52 | |||||
| Price-to-Owner-Earnings | 14.72 | |||||
| PEG Ratio | 4.16 | |||||
| PS Ratio | 1.12 | |||||
| PB Ratio | 1.68 | |||||
| Price-to-Tangible-Book | 1.68 | |||||
| Price-to-Free-Cash-Flow | 18.74 | |||||
| Price-to-Operating-Cash-Flow | 11.79 | |||||
| EV-to-EBIT | 11.8 | |||||
| EV-to-EBITDA | 8.46 | |||||
| EV-to-Revenue | 0.94 | |||||
| EV-to-FCF | 15.69 | |||||
| Price-to-Projected-FCF | 1.2 | |||||
| Price-to-Graham-Number | 1.14 | |||||
| Price-to-Net-Current-Asset-Value | 3.84 | |||||
| Earnings Yield (Greenblatt) % | 8.48 | |||||
| FCF Yield % | 5.33 | |||||
| Forward Rate of Return (Yacktman) % | 1.49 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
EPS Bio Technology Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 477.197 | ||
| EPS (TTM) (NT$) | 1.27 | ||
| Beta | 0.16 | ||
| Volatility % | 37.35 | ||
| 14-Day RSI | 55.67 | ||
| 14-Day ATR (NT$) | 0.564195 | ||
| 20-Day SMA (NT$) | 21.75 | ||
| 12-1 Month Momentum % | 11.99 | ||
| 52-Week Range (NT$) | 19.55 - 30 | ||
| Shares Outstanding (Mil) | 23.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
EPS Bio Technology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
EPS Bio Technology Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
EPS Bio Technology Corp Frequently Asked Questions
What is EPS Bio Technology Corp(ROCO:4183)'s stock price today?
The current price of ROCO:4183 is NT$22.30. The 52 week high of ROCO:4183 is NT$30.00 and 52 week low is NT$19.55.
When is next earnings date of EPS Bio Technology Corp(ROCO:4183)?
The next earnings date of EPS Bio Technology Corp(ROCO:4183) is .
Does EPS Bio Technology Corp(ROCO:4183) pay dividends? If so, how much?
The Dividend Yield %  of EPS Bio Technology Corp(ROCO:4183) is 4.41% (As of Today), Highest Dividend Payout Ratio of EPS Bio Technology Corp(ROCO:4183) was 6.67. The lowest was 0.29. And the median was 0.77. The  Forward Dividend Yield % of EPS Bio Technology Corp(ROCO:4183) is 4.41%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers